We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.


Measles in Europe: Update 1

24 April 2024

The European Centre for Disease Prevention & Control (ECDC) reports continued transmission of measles in Europe in 2024. As of 12 April 2024, countries reporting cases are:

Austria: 374 cases

Belgium: 37 cases, with media reports of an additional 11 cases

Bulgaria: 1 case

Cyprus: 18 cases

Czech Republic: 14 cases

Denmark: 11 cases

Estonia: 1 case

Finland: 1 case

France: 69 cases

Germany: 161 cases

Hungary: 12 cases

Ireland: 13 cases

Italy: 213 cases

Lithuania: 20 cases

Malta: 3 cases

Netherlands: 51 cases

Norway: 1 case

Poland: 40 cases

Portugal: 18 cases

Romania: 11 397 cases (12 deaths)

Slovenia: 3 cases

Spain: 25 cases

Sweden: 5 cases

Switzerland: 58 cases

Ukraine: 9 cases

United Kingdom: 1 023 cases (1 October 2023 to 11 April 2024)

Measles is highly contagious and continuing transmission means there is also risk of spread to countries not currently reporting cases.

Advice for Travellers

Travel may increase an individual’s risk of exposure to measles virus, and facilitate the spread of disease to unvaccinated and susceptible populations. The travel consultation provides a valuable opportunity to ensure individuals are protected against measles, mumps and rubella (MMR) viruses. Two doses of MMR vaccine, at least one month apart, are required to give adequate protection.

Consider vaccinating:

  • all travellers who have not previously had two doses of MMR vaccine or prior measles infection
  • travellers visiting friends and relatives (VFRs), and/or mixing closely with the local population
  • younger children who have not yet been fully immunised

For children, first and second doses of MMR vaccine can be administered earlier than they would routinely be given within the UK Vaccination Schedule (2 doses of MMR vaccine around 12-13 months, and before starting school at around 3 years 4 months of age).

  • MMR vaccine can be given from 6 months of age when early protection is required

See the TRAVAX Measles, Mumps and Rubella page for further information.